SOPH
SOPHiA GENETICS S.A.
NASDAQ · Healthcare · Medical - Healthcare Information Services · CH
$8.16
−1.69%0
Insider buys (3m)
52
Insider sells (3m)
-$2.9M
Net value (3m)
+62.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 31, 2026 | Xu Zhenyu · officer: Chief Scientific Officer | Sale | 10,000 | $8.91 |
| Aug 26, 2026 | Verma Abhimanyu · officer: Chief Technology Officer | Sale | 5,000 | $8.20 |
| Aug 26, 2026 | HIBBS KATHY L · director | Sale | 6,250 | $8.68 |
| Aug 26, 2026 | Menu Philippe · officer: Chief Medical Officer | Sale | 5,000 | $8.68 |
| Aug 21, 2026 | Valente Manuela · officer: Chief People Officer | Sale | 10,000 | $7.94 |
| Aug 21, 2026 | Valente Manuela · officer: Chief People Officer | M-Exempt | 10,000 | $3.20 |
| Aug 21, 2026 | Xu Zhenyu · officer: Chief Scientific Officer | Sale | 5,408 | $8.40 |
| Aug 21, 2026 | Xu Zhenyu · officer: Chief Scientific Officer | Sale | 4,592 | $8.41 |
| Aug 21, 2026 | Xu Zhenyu · officer: Chief Scientific Officer | Sale | 10,000 | $7.94 |
| Aug 14, 2026 | Xu Zhenyu · officer: Chief Scientific Officer | Sale | 4,000 | $7.52 |
| Aug 14, 2026 | Menu Philippe · officer: Chief Medical Officer | Sale | 5,000 | $7.52 |
| Aug 10, 2026 | Camblong Jurgi · director, officer: Executive Chairman | Sale | 20,000 | $7.23 |
| Aug 10, 2026 | Camblong Jurgi · director, officer: Executive Chairman | Sale | 8,500 | $7.61 |
| Aug 10, 2026 | Verma Abhimanyu · officer: Chief Technology Officer | Sale | 5,000 | $7.60 |
| Aug 7, 2026 | Xu Zhenyu · officer: Chief Scientific Officer | Sale | 10,000 | $7.48 |
| Aug 7, 2026 | Xu Zhenyu · officer: Chief Scientific Officer | Sale | 7,000 | $7.02 |
| Aug 7, 2026 | Xu Zhenyu · officer: Chief Scientific Officer | M-Exempt | 7,000 | $3.28 |
| Aug 7, 2026 | Xu Zhenyu · officer: Chief Scientific Officer | Sale | 3,000 | $7.00 |
| Aug 7, 2026 | Xu Zhenyu · officer: Chief Scientific Officer | M-Exempt | 3,000 | $3.28 |
| Aug 5, 2026 | Xu Zhenyu · officer: Chief Scientific Officer | Sale | 10,000 | $6.92 |
| Aug 5, 2026 | Camblong Jurgi · director, officer: Executive Chairman | Sale | 20,000 | $6.92 |
| Aug 5, 2026 | Verma Abhimanyu · officer: Chief Technology Officer | Sale | 5,000 | $6.95 |
| Jul 28, 2026 | Menu Philippe · officer: Chief Medical Officer | Sale | 5,000 | $5.66 |
| Jul 22, 2026 | Camblong Jurgi · director, officer: Executive Chairman | M-Exempt | 4,581 | $3.16 |
| Jul 22, 2026 | Camblong Jurgi · director, officer: Executive Chairman | Sale | 20,000 | $6.63 |
| Jul 22, 2026 | Camblong Jurgi · director, officer: Executive Chairman | Sale | 4,581 | $6.17 |
| Jul 22, 2026 | Camblong Jurgi · director, officer: Executive Chairman | Sale | 19,800 | $6.32 |
| Jul 14, 2026 | Xu Zhenyu · officer: Chief Scientific Officer | Sale | 4,000 | $5.70 |
| Jul 14, 2026 | Menu Philippe · officer: Chief Medical Officer | Sale | 5,000 | $5.70 |
| Jul 14, 2026 | Camblong Jurgi · director, officer: Executive Chairman | Sale | 8,500 | $5.62 |
Institutional positioning
13F filings over the trailing two quarters
New 44Increased 30Reduced 24Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | Unchanged | 6,789,560 | Aug 10, 2026 |
| GENERATION INVESTMENT MANAGEMENT LLP | Unchanged | 6,789,560 | May 14, 2026 |
| AIGH Capital Management LLC | New Position | 3,954,194 | Aug 7, 2026 |
| AKRE CAPITAL MANAGEMENT LLC | Unchanged | 3,719,140 | May 14, 2026 |
| AKRE CAPITAL MANAGEMENT LLC | Unchanged | 3,719,140 | Aug 14, 2026 |
| ROYCE & ASSOCIATES LP | Increased | 3,381,736 | Aug 14, 2026 |
| PRINCIPAL FINANCIAL GROUP INC | Increased | 2,364,256 | Aug 4, 2026 |
| AMERIPRISE FINANCIAL INC | New Position | 2,216,752 | Aug 14, 2026 |
| BANQUE PICTET & CIE SA | Unchanged | 2,208,280 | Jul 24, 2026 |
| BANQUE PICTET & CIE SA | Unchanged | 2,208,280 | Apr 14, 2026 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | New Position | 1,850,000 | May 14, 2026 |
| ROYCE & ASSOCIATES LP | Increased | 1,816,312 | May 12, 2026 |
| AWM Investment Company, Inc. | New Position | 1,700,000 | Aug 14, 2026 |
| Soleus Capital Management, L.P. | Reduced | 1,565,000 | Aug 11, 2026 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | New Position | 1,428,470 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 31, 2026